Research Archives - Charcot-Marie-Tooth UK

20/09/23

Research

Charcot Marie Tooth

Pharnext enters the final stretch for the signature of a licensingagreement for its drug candidate in Charcot-Marie-Tooth disease type 1A(PXT3003), enabling it to capitalize on its assets and put an end to theOCEANE-BSA financing line

12/05/23

Conference

Charcot Marie Tooth

Post CMTUK Conference Round-up 2023

11/04/23

Research

Charcot Marie Tooth

CMTUK Research Grant: Call for applications

Research award 2023 We delighted to announce applications for our new research award for 2023 are now open. The initiation, […]

11/04/23

Membership

Charcot Marie Tooth

CMTUK 2023 Conference: Come and Join Us

7/03/23

Research

Charcot Marie Tooth

CMT Research Foundation Collaborates with Augustine Therapeutics on New Potential Therapy for Charcot-Marie-Tooth Disease

ATLANTA (March 2, 2023) The CMT Research Foundation (CMTRF), a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, is […]

18/10/22

Research

Charcot Marie Tooth

The CMT Research Foundation announce a new project with Samsara Therapeutics, a US/UK-based biotech company that is developing a novel class of drugs for CMT1A.

CMT1A is caused by duplication of a stretch of DNA that includes the PMP22 gene, and people with CMT1A produce approximately […]

Research

Pharnext enters the final stretch for the signature of a licensingagreement for its drug candidate in Charcot-Marie-Tooth disease type 1A(PXT3003), enabling it to capitalize on its assets and put an end to theOCEANE-BSA financing line

Post CMTUK Conference Round-up 2023

CMTUK Research Grant: Call for applications

CMTUK 2023 Conference: Come and Join Us

CMT Research Foundation Collaborates with Augustine Therapeutics on New Potential Therapy for Charcot-Marie-Tooth Disease

The CMT Research Foundation announce a new project with Samsara Therapeutics, a US/UK-based biotech company that is developing a novel class of drugs for CMT1A.

Login